MediWound
MDWD • NASDAQ
MediWound is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ofer Gonen, with a market cap of $193.3M.
CEOOfer Gonen
Next Earnings
Upcoming earnings announcement for MediWound
Date
Wednesday, May 20, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.66
Revenue Estimate
$3.4M
Earnings History
Past 12 earnings reports for MediWound
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.56Est: -$0.63 | +11.1% | $1.9MEst: $2.1M | -9.0% | — |
| Nov 20, 2025 | Q3 2025 | -$0.24Est: -$0.82 | +70.7% | $5.4MEst: $6.5M | -16.6% | — |
| Aug 14, 2025 | Q2 2025 | -$1.23Est: -$0.56 | -119.6% | $5.7MEst: $5.6M | +1.1% | — |
| May 21, 2025 | Q1 2025 | -$0.07Est: -$0.66 | +89.4% | $4.0MEst: $5.2M | -23.9% | — |
| Mar 19, 2025 | Q4 2024 | -$0.36Est: -$0.61 | +41.0% | $5.8MEst: $5.8M | +1.6% | — |
| Nov 26, 2024 | Q3 2024 | -$0.98Est: -$0.44 | -122.7% | $4.4MEst: $6.0M | -27.5% | — |
| Aug 14, 2024 | Q2 2024 | -$0.68Est: -$0.44 | -54.5% | $5.1MEst: $5.1M | +0.1% | — |
| May 29, 2024 | Q1 2024 | -$0.39Est: -$0.41 | +4.9% | $5.0MEst: $4.7M | +6.3% | — |
| Mar 21, 2024 | Q4 2023 | -$0.19Est: -$0.23 | +17.4% | $5.3MEst: $5.3M | +0.3% | — |
| Nov 21, 2023 | Q3 2023 | -$0.24Est: -$0.44 | +45.5% | $4.8MEst: $4.7M | +0.8% | — |
| Aug 15, 2023 | Q2 2023 | $0.10Est: -$0.41 | +124.4% | $4.8MEst: $4.2M | +13.9% | — |
| May 30, 2023 | Q1 2023 | -$0.44Est: -$0.30 | -46.7% | $3.8MEst: $5.2M | -26.2% | — |